Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes
- PMID: 11462032
- PMCID: PMC114995
- DOI: 10.1128/JVI.75.16.7602-7611.2001
Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes
Abstract
Replication-competent adenoviruses are being investigated as potential anticancer agents. Exclusive virus replication in cancer cells has been proposed as a safety trait to be considered in the design of oncolytic adenoviruses. From this perspective, we have investigated several adenovirus mutants for their potential to conditionally replicate and promote the killing of cells expressing human papillomavirus (HPV) E6 and E7 oncoproteins, which are present in a high percentage of anogenital cancers. For this purpose, we have employed an organotypic model of human stratified squamous epithelium derived from primary keratinocytes that have been engineered to express HPV-18 oncoproteins stably. We show that, whereas wild-type adenovirus promotes a widespread cytopathic effect in all infected cells, E1A- and E1A/E1B-deleted adenoviruses cause no deleterious effect regardless of the coexpression of HPV18 E6E7. An adenovirus deleted in the CR2 domain of E1A, necessary for binding to the pRB family of pocket proteins, shows no selectivity of replication as it efficiently kills all normal and E6E7-expressing keratinocytes. Finally, an adenovirus mutant deleted in the CR1 and CR2 domains of E1A exhibits preferential replication and cell killing in HPV E6E7-expressing cultures. We conclude that the organotypic keratinocyte culture represents a distinct model to evaluate adenovirus selectivity and that, based on this model, further modifications of the adenovirus genome are required to restrict adenovirus replication to tumor cells.
Figures
Similar articles
-
Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes.J Virol. 2003 Jun;77(11):6533-40. doi: 10.1128/jvi.77.11.6533-6540.2003. J Virol. 2003. PMID: 12743310 Free PMC article.
-
E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.Hum Gene Ther. 2007 Sep;18(9):773-86. doi: 10.1089/hum.2006.167. Hum Gene Ther. 2007. PMID: 17725410
-
Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes.Mol Ther. 2001 Sep;4(3):211-6. doi: 10.1006/mthe.2001.0447. Mol Ther. 2001. PMID: 11545611
-
Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.Princess Takamatsu Symp. 1991;22:239-48. Princess Takamatsu Symp. 1991. PMID: 1668886 Review.
-
Molecular mechanisms of transformation by the human papillomaviruses.Princess Takamatsu Symp. 1989;20:199-206. Princess Takamatsu Symp. 1989. PMID: 2562182 Review.
Cited by
-
Current developments in adenovirus-based cancer gene therapy.Future Oncol. 2006 Feb;2(1):137-43. doi: 10.2217/14796694.2.1.137. Future Oncol. 2006. PMID: 16556080 Free PMC article. Review.
-
Current issues and future directions of oncolytic adenoviruses.Mol Ther. 2010 Feb;18(2):243-50. doi: 10.1038/mt.2009.266. Epub 2009 Nov 24. Mol Ther. 2010. PMID: 19935777 Free PMC article. Review.
-
Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.J Neurooncol. 2003 Dec;65(3):237-46. doi: 10.1023/b:neon.0000003653.45635.32. J Neurooncol. 2003. PMID: 14682374 Review.
-
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy.Mol Ther Oncolytics. 2017 Mar 21;5:20-40. doi: 10.1016/j.omto.2017.03.002. eCollection 2017 Jun 16. Mol Ther Oncolytics. 2017. PMID: 28480326 Free PMC article. Review.
-
Three-dimensional tumor cell cultures employed in virotherapy research.Oncolytic Virother. 2018 Sep 5;7:79-93. doi: 10.2147/OV.S165479. eCollection 2018. Oncolytic Virother. 2018. PMID: 30234074 Free PMC article. Review.
References
-
- Alemany R, Balagué C, Curiel D T. Replicative adenoviruses for cancer therapy. Nat Biotechnol. 2000;18:723–727. - PubMed
-
- Alemany R, Lai S, Lou Y C, Jan H Y, Fang X, Zhang W W. Complementary adenoviral vectors for oncolysis. Cancer Gene Ther. 1999;6:21–25. - PubMed
-
- Alemany R, Ruan S, Kataoka M, Koch P E, Mukhopadhyay T, Cristiano R J, Roth J A, Zhang W W. Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells. Cancer Gene Ther. 1996;3:296–301. - PubMed
-
- Aneskievich B J, Taichman L B. Epithelium-specific response of cultured keratinocytes to infection with adenovirus type 2. J Investig Dermatol. 1988;91:309–314. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources